AGENUS INC — Director's Dealing 2010

Jan 21, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-01-19

Reporting Person: Valentine Karen (VP and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-01-19	Common Stock	A	93789	$0.9	Acquired	174319	Direct
2010-01-20	Common Stock	S	93789	$0.8534	Acquired	80530	Direct

Footnotes

F1: Represents settlement of restricted stock granted on January 19, 2010 in lieu of an annual cash bonus for 2009 performance.

F2: Represents the sale of shares obtained from the vesting of restricted stock granted on January 19, 2010 in lieu of an annual cash bonus for 2009 performance. This sale has been made through a Rule 10b5-1 trading plan.